Thomas George Larson

Array ( [id] => 3943513 [patent_doc_number] => 05990089 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Self-assembling polynucleotide delivery system comprising dendrimer polycations' [patent_app_type] => 1 [patent_app_number] => 8/486826 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 18200 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990089.pdf [firstpage_image] =>[orig_patent_app_number] => 486826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3744665 [patent_doc_number] => 05716846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Method for inhibiting cellular proliferation using antisense oligonucleotides to interleukin-6 receptor mRNA' [patent_app_type] => 1 [patent_app_number] => 8/486408 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5418 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716846.pdf [firstpage_image] =>[orig_patent_app_number] => 486408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3802558 [patent_doc_number] => 05830653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Methods of using oligomers containing modified pyrimidines' [patent_app_type] => 1 [patent_app_number] => 8/473481 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 42383 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830653.pdf [firstpage_image] =>[orig_patent_app_number] => 473481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769476 [patent_doc_number] => 05756352 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Thiocationic lipid-nucleic acid conjugates' [patent_app_type] => 1 [patent_app_number] => 8/480204 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10234 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 258 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756352.pdf [firstpage_image] =>[orig_patent_app_number] => 480204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692477 [patent_doc_number] => 05679555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Method of using ribozyme analogs having rigid, non-nucleotidic molecular linkers' [patent_app_type] => 1 [patent_app_number] => 8/478940 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 10660 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679555.pdf [firstpage_image] =>[orig_patent_app_number] => 478940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4060649 [patent_doc_number] => 05866327 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Association of kinensin with sensitivity to chemotherapeutic drugs' [patent_app_type] => 1 [patent_app_number] => 8/486382 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 11427 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866327.pdf [firstpage_image] =>[orig_patent_app_number] => 486382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624524 [patent_doc_number] => 05594121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Enhanced triple-helix and double-helix formation with oligomers containing modified purines' [patent_app_type] => 1 [patent_app_number] => 8/479248 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 20112 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/594/05594121.pdf [firstpage_image] =>[orig_patent_app_number] => 479248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151115 [patent_doc_number] => 06113946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Self-assembling polynucleotide delivery system comprising dendrimer polycations' [patent_app_type] => 1 [patent_app_number] => 8/469433 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 18984 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113946.pdf [firstpage_image] =>[orig_patent_app_number] => 469433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775675 [patent_doc_number] => 05808036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Stem-loop oligonucleotides containing parallel and antiparallel binding domains' [patent_app_type] => 1 [patent_app_number] => 8/466670 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21355 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808036.pdf [firstpage_image] =>[orig_patent_app_number] => 466670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790082 [patent_doc_number] => 05840875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Kidney Na/PO.sub.4 cotransporter antisense oligonucleotide' [patent_app_type] => 1 [patent_app_number] => 8/467007 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 6847 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840875.pdf [firstpage_image] =>[orig_patent_app_number] => 467007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838397 [patent_doc_number] => 05744362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Antisense oligonucleotide modulation of raf gene expression' [patent_app_type] => 1 [patent_app_number] => 8/463912 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8459 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744362.pdf [firstpage_image] =>[orig_patent_app_number] => 463912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686463 [patent_doc_number] => 05695997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Tetrapeptide' [patent_app_type] => 1 [patent_app_number] => 8/459641 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3330 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695997.pdf [firstpage_image] =>[orig_patent_app_number] => 459641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661586 [patent_doc_number] => 05656612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Antisense oligonucleotide modulation of raf gene expression' [patent_app_type] => 1 [patent_app_number] => 8/460235 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8477 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656612.pdf [firstpage_image] =>[orig_patent_app_number] => 460235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772610 [patent_doc_number] => 05807837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Composition and method for the treatment or prophylaxis of viral infections using modified oligodeoxyribonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/457151 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90187 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807837.pdf [firstpage_image] =>[orig_patent_app_number] => 457151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741706 [patent_doc_number] => 05801013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Helicobacter aminoacyl-tRNA synthetase proteins, nucleic acids and strains comprising same' [patent_app_type] => 1 [patent_app_number] => 8/451715 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33908 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801013.pdf [firstpage_image] =>[orig_patent_app_number] => 451715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3879533 [patent_doc_number] => 05747641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Tat-derived transport polypeptide conjugates' [patent_app_type] => 1 [patent_app_number] => 8/451233 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 34039 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747641.pdf [firstpage_image] =>[orig_patent_app_number] => 451233 [rel_patent_id] =>[rel_patent_doc_number] =>)